Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.JAMA. 1994 May 11; 271(18):1429-35.JAMA
Links
MeSH
2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer AgentsBlood Chemical AnalysisCombined Modality TherapyDuodenal NeoplasmsFemaleGastric AcidGastric MucosaGastrinomaGastrinsHepatic ArteryHumansInterferonsLansoprazoleMaleMiddle AgedMultiple Endocrine NeoplasiaOmeprazolePancreatic NeoplasmsPeptic UlcerSplenic ArteryZollinger-Ellison Syndrome
Pub Type(s)
Case Reports
Clinical Conference
Journal Article
Language
eng
PubMed ID
7513768
Citation
Jensen, R T., and D L. Fraker. "Zollinger-Ellison Syndrome. Advances in Treatment of Gastric Hypersecretion and the Gastrinoma." JAMA, vol. 271, no. 18, 1994, pp. 1429-35.
Jensen RT, Fraker DL. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA. 1994;271(18):1429-35.
Jensen, R. T., & Fraker, D. L. (1994). Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA, 271(18), 1429-35.
Jensen RT, Fraker DL. Zollinger-Ellison Syndrome. Advances in Treatment of Gastric Hypersecretion and the Gastrinoma. JAMA. 1994 May 11;271(18):1429-35. PubMed PMID: 7513768.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
AU - Jensen,R T,
AU - Fraker,D L,
PY - 1994/5/11/pubmed
PY - 1994/5/11/medline
PY - 1994/5/11/entrez
SP - 1429
EP - 35
JF - JAMA
JO - JAMA
VL - 271
IS - 18
SN - 0098-7484
UR - https://www.unboundmedicine.com/medline/citation/7513768/Zollinger_Ellison_syndrome__Advances_in_treatment_of_gastric_hypersecretion_and_the_gastrinoma_
L2 - https://jamanetwork.com/journals/jama/fullarticle/vol/271/pg/1429
DB - PRIME
DP - Unbound Medicine
ER -